Jeremy Friedler, M.S.

Jeremy Friedler is an experienced biopharma consultant with 13 years of strategy and operations experience in the life sciences industry.  He brings deep knowledge and analytical expertise in Manufacturing and Supply Chain Management, Quality, Commercial Launch Planning, Regulatory, Medical Affairs, and Clinical Development.  Jeremy’s work with pharmaceutical, biopharmaceutical as well as cell and gene therapy companies has given him a unique and well-rounded perspective, and experience addressing a wide range of challenges faced by emerging and growing biopharma clients.  

Prior to his work with Converge, Jeremy was a Senior Manager in the Pharmaceutical and Life Sciences practice at PricewaterhouseCoopers’, providing advisory services to a spectrum of clients including large, global pharmaceutical companies, small to mid-sized and emerging biotech companies.  In this role, he ensured the timely execution of post-merger integration milestones for a $74B biopharmaceutical merger.  He also led commercial launch planning, cross-functional readiness assessments, and implemented strategies for organizational improvement.

In earlier roles, Jeremy served as a Supply Chain Associate at Alnylam Pharmaceuticals and as a consultant with AMR Research.  He honed his supply chain planning skills in the Strategy & Operations practice of Maxiom Consulting Group.  Working primarily with emerging biotech clients, he developed and implemented supply chain strategies and supported commercial launch preparations for innovative treatments

Jeremy earned his Masters Degree in Supply Chain Management from Northeastern University, and previously earned a Bachelor of Arts Degree from Franklin & Marshall College.

Northeastern University
M.S. in Supply Chain Management

Franklin & Marshall College
B.A.